Mutations in parkin lead to early-onset autosomal recessive Parkinson's disease (PD) and inactivation of parkin is thought to contribute to sporadic PD. Adult knockout of parkin in the ventral midbrain of mice leads to an age-dependent loss of dopamine neurons that is dependent on the accumulation of parkin interacting substrate (PARIS), zinc finger protein 746 (ZNF746), and its transcriptional repression of PGC-1α. Here we show that adult knockout of parkin in mouse ventral midbrain leads to decreases in mitochondrial size, number, and protein markers consistent with a defect in mitochondrial biogenesis. This decrease in mitochondrial mass is prevented by short hairpin RNA knockdown of PARIS. PARIS overexpression in mouse ventral midbrain leads to decreases in mitochondrial number and protein markers and PGC-1α-dependent deficits in mitochondrial respiration. Taken together, these results suggest that parkin loss impairs mitochondrial biogenesis, leading to declining function of the mitochondrial pool and cell death. Recently, the parkin interacting substrate (PARIS) also known as zinc finger protein 746 (ZNF746) was shown to be required for loss of DA neurons in adult conditional parkin knockout (KO) mice (19). PARIS is polyubiquitinated by parkin via lysine-48 targeting it for ubiquitin proteasomal degradation. Deletion of parkin in adult mice leads to an age-dependent progressive loss of DA neurons that is due to the accumulation of PARIS because depletion of PARIS in adult conditional parkin knockout mice prevents the loss of DA neurons (19). PARIS is a transcriptional repressor that regulates the expression of peroxisome proliferator-activated receptor gamma, coactivator 1α (PGC-1α), a master coregulator of mitochondrial function, biogenesis, and mitochondrial oxidative stress management (19, 20) . In adult conditional parkin knockout mice, there is a reduction in PGC-1α levels that is dependent on PARIS because reduction in PARIS reverses the reduction in PGC-1α levels (19). PARIS overexpression, at levels equivalent to those in the adult conditional parkin knockout mice, also leads to defects in PGC-1α and causes the selective loss of DA neurons (19). PGC-1α overexpression prevents the defects in PGC-1α signaling and the loss of DA neurons, suggesting that PARIS kills DA neurons in a PGC-1α-dependent fashion (19).
Mutations in parkin lead to early-onset autosomal recessive Parkinson's disease (PD) and inactivation of parkin is thought to contribute to sporadic PD. Adult knockout of parkin in the ventral midbrain of mice leads to an age-dependent loss of dopamine neurons that is dependent on the accumulation of parkin interacting substrate (PARIS), zinc finger protein 746 (ZNF746), and its transcriptional repression of PGC-1α. Here we show that adult knockout of parkin in mouse ventral midbrain leads to decreases in mitochondrial size, number, and protein markers consistent with a defect in mitochondrial biogenesis. This decrease in mitochondrial mass is prevented by short hairpin RNA knockdown of PARIS. PARIS overexpression in mouse ventral midbrain leads to decreases in mitochondrial number and protein markers and PGC-1α-dependent deficits in mitochondrial respiration. Taken together, these results suggest that parkin loss impairs mitochondrial biogenesis, leading to declining function of the mitochondrial pool and cell death.
Parkinson's disease | ZNF746 | mitochondrial biogenesis | PARIS | parkin P arkin, an ubiquitin E3 ligase, is linked to autosomal recessive Parkinson's disease (PD) through loss-of-function mutations (1, 2) and to sporadic PD through posttranslational inactivation (reviewed in refs. [3] [4] [5] . A number of theories have been postulated to account for PD due to parkin inactivation, but it is clear that the loss of parkin's ubiquitin E3 ligase activity plays a central role in the loss of dopamine (DA) neurons in parkin-linked PD. Parkin conjugates ubiquitin to a variety of proteins using various ubiquitin lysine linkages, including polyubiquitination via lysine-27, -29, -63, and lysine-48 linkages as well as monoubiquitination via lysine-48. Each subtype of parkin ubiquitination has been linked to different physiologic processes (5) (6) (7) . Polyubiquitination via lysine-48 leads to proteasomal degradation of parkin substrates, and in the absence of parkin these substrates accumulate and contribute to the loss of DA neurons in PD due to parkin inactivation (8-17) (for review see ref. 18) .
Recently, the parkin interacting substrate (PARIS) also known as zinc finger protein 746 (ZNF746) was shown to be required for loss of DA neurons in adult conditional parkin knockout (KO) mice (19) . PARIS is polyubiquitinated by parkin via lysine-48 targeting it for ubiquitin proteasomal degradation. Deletion of parkin in adult mice leads to an age-dependent progressive loss of DA neurons that is due to the accumulation of PARIS because depletion of PARIS in adult conditional parkin knockout mice prevents the loss of DA neurons (19) . PARIS is a transcriptional repressor that regulates the expression of peroxisome proliferator-activated receptor gamma, coactivator 1α (PGC-1α), a master coregulator of mitochondrial function, biogenesis, and mitochondrial oxidative stress management (19, 20) . In adult conditional parkin knockout mice, there is a reduction in PGC-1α levels that is dependent on PARIS because reduction in PARIS reverses the reduction in PGC-1α levels (19) . PARIS overexpression, at levels equivalent to those in the adult conditional parkin knockout mice, also leads to defects in PGC-1α and causes the selective loss of DA neurons (19) . PGC-1α overexpression prevents the defects in PGC-1α signaling and the loss of DA neurons, suggesting that PARIS kills DA neurons in a PGC-1α-dependent fashion (19) .
Because PGC-1α is a master coregulator of mitochondrial function and mitochondrial defects are a consistent feature of PD, mitochondria were assessed in the adult conditional parkin knockout mice. Here we show that adult conditional knockout of parkin leads to reductions in mitochondrial mass that are dependent upon PARIS. Moreover, PARIS accumulation leads to substantial deficits in mitochondrial respiration that are PGC-1α dependent. Our findings are consistent with parkin regulation of mitochondrial biogenesis.
Results
Reduced Mitochondrial Size and Number in Adult Conditional Parkin Knockouts. Adult conditional parkin knockout mice were generated as previously described by injecting a lentivirus expressing GFPCre stereotactically into the ventral midbrain of 2-mo-old parkin flx/flx mice ( Fig. S1A) (19) . In a subset of mice a lentivirus expressing PARIS Significance Mutations or inactivation of parkin causes Parkinson's disease (PD) in humans. Recent studies have focused on parkin's role in mitochondrial quality control in the pathogenesis of PD, including defects in mitophagy, mitochondrial fission, fusion, and transport. This study shows that parkin also controls mitochondrial biogenesis and that defects in mitochondrial biogenesis drive the loss of dopamine (DA) neurons due to the absence of parkin. The findings support the role of parkin in regulating multiple arms of mitochondrial quality control and suggest that maintaining mitochondrial biogenesis is critically important in the survival of DA neurons.
short hairpin RNA (shRNA) was coinjected to prevent the up-regulation of PARIS due to the deletion of parkin as previously described (19) . Lenti-GFPCre leads to almost complete loss of parkin from the ventral midbrain of parkin flx/flx mice compared with lenti-GFP mice (Fig. S1B) . Accompanying the loss of parkin is a robust up-regulation of PARIS, resulting in reduction of PGC-1α and nuclear respiratory factor (NRF-1) as previously described (19) (Fig. S1B) . Immunostaining for GFP in the intranigral GFP-or GFPCre-injected mice demonstrates that lenti-GFP and lentiGFPCre effectively transduce neurons in the substantia nigra (SN) including DA neurons (Fig. S1C) . Nine months later when active loss of DA neurons is occurring, transmission electron microscopic (TEM) images from the SN were collected to determine the effects of the loss of parkin on nuclear and mitochondrial morphology. Adult knockout of parkin in the SN of mice leads to the clumping of nuclear chromatin and pyknotic nuclei (Fig. S1D) . Different levels of clumping of the nuclear chromatin are observed with mild to compact nuclear clumping suggestive of different stages of degeneration (Fig. S1D ). In addition, dead cells are observed (Fig. S1  D and E) . Quantification of the pyknotic nuclei reveals a significant increase in the percentage of pyknotic nuclei in the adult conditional parkin knockout mice compared with lenti-GFP-injected control mice ( Fig. S1 E and F) . Knockdown of PARIS via lenti-PARIS shRNA substantially and significantly reduces the percentage of pyknotic nuclei ( Fig. S1 E and F). Previous observations assessing tyrosine hydroxylase (TH) number in the SN via stereology (19) are consistent with number of pyknotic nuclei due to adult conditional parkin knockout and rescue by coadministration of lenti-PARIS shRNA (Fig. S1 D and E) . In ventral midbrain neurons with normal appearing nuclei, TEM image analysis of mitochondrial number and size was performed ( Fig. 1 A and B) . Mitochondria in the adult conditional parkin knockout mice are smaller in size and number and they have abnormal appearing cristae compared with lenti-GFP-injected control mice ( Fig. 1 A and B) . Mitochondria in the adult conditional parkin knockout mice with knockdown of PARIS via lenti-PARIS shRNA have normal appearing mitochondria ( Fig. 1 A and B) . Quantification reveals a 32% reduction in mitochondrial number in adult conditional parkin knockout mice compared with lenti-GFP-injected SN, and knockdown of PARIS via lenti-PARIS shRNA prevents the reduction in mitochondrial number (Fig. 1C) . Mitochondria in adult conditional parkin knockout mice are 40% smaller than lenti-GFP-injected SN, and knockdown of PARIS via lenti-PARIS shRNA prevents the reduction in mitochondrial size (Fig. 1D ). In adult conditional parkin knockout mice, 69% of the mitochondria have abnormal cristae compared with lenti-GFP-injected SN, and knockdown of PARIS via lenti-PARIS shRNA substantially and significantly prevents the formation of abnormal cristae (Fig. 1E ).
Reduced Mitochondrial Content in DA Neurons of Adult Conditional
Parkin Knockouts. The TEM analysis suggests that there is reduced mitochondrial numbers in adult conditional parkin knockout mice. To confirm whether mitochondrial number is reduced in adult conditional parkin knockout mice, mitochondrial DNA (mtDNA) copy number was assessed in the adult conditional parkin KO ventral midbrain by measuring two different mitochondrial markers, cytochrome C oxidase (COX) and cytochrome b (CYTB) using real-time quantitative PCR ( Fig.  2A) . Conditional knockout of parkin in adult mice results in an ∼60% reduction in mitochondrial DNA copy number as assessed by COX and CYTB levels ( Fig. 2A) . Administration of lentiviral shRNA-PARIS along with lenti-GFPCre significantly reverses the change in COX and CYTB levels ( Fig. 2A) . To ascertain whether the reduction of COX and CYTB levels is cell autonomous in DA neurons, laser capture microdissection (LCM) was performed in conditional parkin KO mice 4 wk after the lentiGFPCre injection to obtain DNA and RNA from TH-positive neurons transduced with GFPCre ( Fig. 2 B and C) . We find a significant reduction of COX and CYTB levels in TH-positive DA neurons of conditional parkin KO mice, whereas the levels of TH mRNA are unchanged (Fig. 2D ). Because these changes occur before observation of significant degeneration, reductions in mitochondrial markers in DA neurons likely precedes neuronal degeneration.
To confirm that the absence of parkin causes a reduction in mitochondrial number, shRNA knockdown of parkin was performed in the SH-SY5Y cell line (Fig. S2 ). Parkin knockdown via shRNA leads to a significant reduction of mitochondrial copy number as assessed by determining the ratio of the mitochondrial-encoded NADH dehydrogenase 1 (ND1) gene to genomic β-actin as measured by realtime quantitative PCR (Fig. S2A ). The reduction in mitochondrial copy number is restored by shRNA-PARIS coadministration (Fig.  S2A) . There is also a significant reduction of COXI levels induced by parkin knockdown that is PARIS dependent (Fig. S2B) . Further analysis indicates that shRNA knockdown of parkin in the SH-SY5Y The results were evaluated for statistical significance by applying the KruskalWallis test (C and D) or one-way ANOVA with Tukey's post hoc test (F = 439.7, R 2 = 0.7235) (E). Data are expressed as median with interquartile range (75th and 25th quartiles) (C and D) or mean ± SEM (E). Differences were considered significant when ***P < 0.001. Asterisk indicates statistical significance compared with lenti-GFP vs. lenti-GFPCre and lenti-GFPCre vs. lenti-GFPCre along with lenti-shRNA-PARIS, respectively.
catecholaminergic cell line causes a twofold increase in the level of PARIS followed by a reduction of PGC-1α and the mitochondrial proteins pyruvate dehydrogenase alpha (PDHA), COXIV, and voltage-dependent anion channel (VDAC), whereas succinate dehydrogenase complex, subunit A (SDHA) did not decrease (Fig. S2  C and D) . To assess the functional consequences of the observed deficits, we conducted microplate-based respirometry in SHSY-5Y cells transduced with either shRNA-dsRED or shRNA-parkin. Parkin knockdown led to a 38% reduction in basal respiration, a 48% reduction in maximal respiration, and a 63% loss of functional reserve capacity (Fig. S2 E and F) . To determine whether the reduction in PGC-1α and the mitochondrial proteins induced by the absence of parkin is dependent on the presence of PARIS, a double knockdown experiment was performed by lentiviral transduction of shRNA against parkin and PARIS in SH-SY5Y cells (Fig. S2 C and  D) . Knockdown of PARIS prevents the down-regulation of PGC-1α and the mitochondrial proteins induced by parkin knockdown (Fig.  S2 C and D) . As previously described, knockdown of parkin leads to a reduction in the mRNA for PGC-1α and this reduction is eliminated by PARIS knockdown and PARIS knockdown dramatically increases PGC-1α mRNA (19) (Fig. S2G) .
Parkin has been touted to play a role in mitochondrial autophagy (mitophagy). If there were defects in mitophagy, one would expect the absence of parkin to increase mitochondrial number through impaired clearance of mitochondrial. However, the deletion of parkin instead leads to reduced mitochondrial number (Fig. 1) . To confirm that adult conditional parkin knockout mice do not have a defect in autophagy, the levels of the cytosolic sequestosome 1 (p62) (21) were assessed along with the levels of the microtubule-associated proteins 1A/1B light chain 3 (LC-3) processing from LC-3I to LC-3II (22) (Fig. S3) . There is a reduction in LC-3II levels, and there was no substantial change in the levels of p62 after knockout of parkin (Fig. S3) . In addition, dense core lysosomes are observed around degenerating or necrotic mitochondria (Fig. S1G) . These results taken together suggest that the adult conditional parkin knockout mice do not have substantial defects in mitophagy.
Overexpression of PARIS Leads to Reduced Mitochondrial Markers.
Because PARIS is up-regulated in PD and the conditional parkin KO mice (19) , a PARIS overexpression model was used as previously described (19) in which adeno-associated virus serotype 1 (AAV1)-PARIS was stereotactically injected into the SN of C57BL/6 mice and compared with mice injected with control AAV1-GFP virus (Fig. 3A) . Stereotactic intranigral injection of AAV1 effectively transduces the entire SN (19) . One month after stereotactic injection of the viruses, PARIS, PDHA, COXIV, VDAC, SDHA, and superoxide dismutase 1 (SOD1) protein levels were determined. AAV1-mediated overexpression of PARIS leads to a greater than twofold up-regulation of PARIS levels in the SN of mice similar to the level of up-regulation of PARIS in sporadic PD and the conditional parkin KO mice (Fig. 3 B and C) (19) . Accompanying the increase in PARIS levels is a down-regulation of PDHA, COXIV, VDAC, and SDHA and a trend toward a reduction in SOD1 (Fig. 3 B and C) . To assess whether PARIS overexpression has an effect on mitochondrial number, the level of COXIV was assessed and normalized to β-actin via Western blot (Fig. 3 D and E) . PARIS overexpression significantly reduces COXIV levels, which are rescued by either AAV1-parkin or lenti-PGC-1α (Fig. 3 D and E) . To assess whether PARIS overexpression has an effect on mtDNA copy number, the ratio of mitochondrial ND1 gene to genomic β-actin (23) was measured by real-time quantitative PCR in SH-SY5Y cells transfected with GFP-tagged wild-type (WT) PARIS or GFP-tagged C571A mutant PARIS, which lacks transcriptional repressive activity (19) (Fig. S2H) . WT PARIS overexpression leads to a significant 56% reduction of mtDNA copy number, whereas overexpression of C571A mutant PARIS does not affect mtDNA copy number (Fig. S2H) .
PARIS Overexpression Leads to Reduced Mitochondrial Number and
Structural Abnormalities. TEM images from SN were collected 4 wk after stereotactic injection of AAV1-GFP or AAV1-PARIS into the SN of WT mice to determine the effects of PARIS overexpression on nuclear and mitochondrial morphology (Fig. 4) . PARIS overexpression in the SN of mice leads to the clumping of nuclear chromatin and pyknotic nuclei (Fig. S4 A and B) . In AAV1-PARIS-injected SN, 43% of the cells examined have shrunken pyknotic nuclei compared with 15% of the control AAV1-GFP-injected SN similar to adult conditional parkin knockout mice (Fig. S4 A and B) . In neurons with normal appearing nuclei, TEM image analysis reveals a 23% reduction in mitochondrial number in AAV1-PARIS-injected SN compared with AAV1-GFP-injected SN (Fig. 5 A and B) . Interestingly, the mitochondria in AAV1-PARIS-injected SN are two times bigger than those in AAV1-GFP-injected SN (0.71 μm 2 vs. 0.39 μm 2 , respectively) (Fig. 4 A and C) . In AAV1-PARIS-injected SN, 47.5% of the mitochondria have loss of organized cristae compared with 14.8% in control-injected SN (Fig. 4 A and C) . Dense core lysosomes are also frequently noted to be clustered around mitochondria (Fig. S4C) . No substantial difference in mitochondrial number, size, and ultrastructure is observed in AAV1-GFP-or AAV1-PARIS-injected mouse cortex (Fig. S5 A and B) . In addition, there is no reduction in the mitochondrial proteins COXIV, NDUFA9, or SDHA (Fig. S5C) . Thus, PARIS overexpression does not cause the same dysfunction of mitochondria in other regions of brain.
PARIS Overexpression Leads to PGC-1α-Dependent Mitochondrial
Respiratory Decline. To ascertain the effect of PARIS overexpression on mitochondrial function, mitochondrial respiration was measured in primary ventral midbrain cultures using a XF-24 analyzer (Seahorse Bioscience). TH immunostaining indicates that 10.9 ± 2.2% of the total cells in cultures are DA neurons (Fig.  5A) . Lentiviral PARIS transduction leads to a two-to threefold increase in PARIS levels compared with GFP transduced control, similar to the relative increase of PARIS in sporadic PD and in the conditional parkin KO mouse (Fig. 5 B and C) (19) . In this system increased PARIS levels lead to a 54% reduction in PGC-1α transcription (Fig. 5D) . We assessed mitochondrial respiration and observed a 29% reduction in basal respiration, a 45% reduction in carbonyl cyanide m-chlorophenyl hydrazine (CCCP)-induced maximal respiration, and a 69% reduction in spare respiratory capacity (Fig. 5E ). These deficits were rescued by restoring PGC-1α levels. Because PGC-1β modulates many of the same target genes as PGC-1α, we assessed whether PARIS regulates PGC-1β. In SH-SY5Y cells transfected with Flag-tagged PARIS, PGC-1β levels are not changed, whereas PGC-1α levels are reduced (Fig. S6A) . Moreover, PGC-1β promoter reporter activity is unaltered (Fig. S6B) . Taken together, these results indicate that PARIS selectively regulates PGC-1α as previously described (19) .
Discussion
The major findings of this manuscript are the observations of reduced mitochondrial size and number along with increased structural abnormalities after adult knockout of parkin in the ventral midbrain of mice. Accompanying the reduction in mitochondrial size and number is a reduction in mitochondrial markers such as PDHA, VDAC, and COXIV. These changes in mitochondrial mass are due to the accumulation of PARIS because knockdown of PARIS eliminates or markedly reduces the changes in mitochondrial mass. Parkin knockdown in SHSY5Y cells recapitulates reductions in mitochondrial DNA copy number and (E) Quantitation of COXIV in D normalized to β-actin. Data are expressed as mean ± SEM. The results were evaluated for statistical significance by applying the unpaired t test (C) or one-way ANOVA with Tukey's post hoc test (F = 6.803, R 2 = 0.7184) (E). Differences were considered significant when P < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001). protein markers and leads to concomitant reduction in respiratory function and capacity.
Moreover PARIS overexpression is sufficient to induce deficits in mitochondrial number, increases in abnormal cristae, and reduction of mitochondrial protein markers selectively in the cells of the ventral midbrain. Overexpression of PARIS in primary mouse ventral midbrain cultures leads to reduced oxygen consumption and impaired respiratory reserve capacity consistent with the reduction in mitochondrial mass. In contrast to our findings in the adult conditional parkin knockout, mitochondrial size was increased in AAV1-PARIS-injected mice. One possible reason for this observation may be that the overexpression of PARIS in conjunction with fully functional parkin impairs biogenesis without a direct impact on parkin-mediated regulation of mitochondrial dynamics or mitophagy. Nonetheless, the overall similar reduction in mitochondrial mass, protein markers, and respiratory capacity, coupled with the PARIS-dependent nature of these observations in the parkin knockout models suggests an overall redundancy in the pathogenic mechanism.
Because PARIS is a transcriptional repressor that accumulates and regulates the levels of PGC-1α specifically in DA neurons (19) , the reduction in mitochondrial number, indices, and function in the adult conditional parkin knockout mice is likely due to PARIS-mediated repression of PGC-1α. PGC-1α is a major regulator of mitochondrial size, number, and function (24) . Methylation of the PGC-1α promoter is known to lead to decreased mitochondrial size and number and decreases in respiratory chain components (25) . Thus, chronic repression of the PGC-1α promoter by PARIS accumulation, as seen in parkin inactivation, likely hinders the production of new mitochondrial proteins, leading to reductions in overall cellular mitochondrial content. This reduction of mitochondria may in turn cause the defects in oxidative phosphorylation (19, 26) .
Whereas studies in patient tissues and genetic models frequently report impaired mitochondrial function, few studies have looked at mitochondrial number in PD or PD models. In Drosophila studies, parkin loss seems to lead to increased mitochondrial size; however, studies in mammalian neurons suggest that parkin loss leads to an increased prevalence of smaller mitochondria and a reduced fractional volume of mitochondria. Germ-line parkin knockout mice exhibit reductions in a number of mitochondrial proteins without observed changes in mitochondrial morphology or DA neuron loss (27, 28) . A recent report shows reduced mitochondrial fractional volume in DA neurons from patients with parkin mutations as well as in DA cells from an isogenic parkin KO-inducible pluripotent stem cell line (28) . Whereas PGC-1α is involved in transcriptional regulation of numerous bioenergetic and antioxidant pathways we focused primarily on investigating defects of oxidative phosphorylation because of its importance in energy production in neurons as well as previous evidence of ox/phos defects found in the PD literature. Further study would be need to investigate the differential impact of parkin loss on other metabolic pathways.
Parkin has been touted to regulate mitochondrial quality control including mitophagy, transport, fission, and fusion (for review see ref. 29) . Our findings would suggest that parkin also regulates mitochondrial number and size in a PARIS-dependent manner. The reduction in mitochondrial number, size, function, and markers coupled with consistent and chronic PGC-1α repression suggests that the absence of parkin leads to a mitochondrial biogenesis defect.
Defects in mitophagy were not observed in adult conditional parkin knockouts and would not explain the observations reported here. One might expect increased mitochondrial number and proteins if there were defects in mitophagy, but instead mitochondrial number and markers were reduced. Other investigators have failed to observe mitophagy defects in parkin knockouts and in patients with parkin mutations (27) . In addition, mitophagy defects were not observed even in the setting of mitochondrial stressors in parkin knockouts (30, 31) . We cannot exclude the possibility that there are defects in mitophagy, transport, fission, and fusion due to the absence of parkin and up-regulation of PARIS, but our data would suggest the PARIS up-regulation and PGC-1α suppression and decrements in mitochondrial biogenesis are the primary driver of DA neuron loss. Under physiologic conditions in the presence of parkin, there is likely a homeostatic mechanisms that regulates the level of mitochondrial numbers in response to the needs of the cell in a balanced pathway of degradation (mitophagy) and production (biogenesis) of mitochondria that is regulated by parkin, with PARIS playing a central role in the biogenesis arm. Consistent with the notion of a homeostatic mechanism is the recent report of the coordination of mitophagy and mitochondrial biogenesis during aging in Caenorhabditis elegans (32) . Further studies are required to investigate this possibility.
In light of the experimental findings that PARIS regulates PGC-1α, mitochondrial integrity, and dopaminergic neuronal viability, it is likely that increased PARIS levels in PD due to parkin inactivation contribute to the pathogenesis of this neurodegenerative disease through down-regulation of PGC-1α and some of its target genes. Consistent with this notion, the loss of DA neurons and many of the mitochondrial abnormalities are (D) Lentiviral PARIS-transduced cultures exhibited a 54.1% reduction in PGC-1α transcript levels (n = 6). Transcript levels were restored by transduction with lentiviral PGC-1α (n = 3). (E) Mitochondrial stress testing of the cultures. PARIS overexpression caused a 29.0 ± 6.3% decrease in basal respiration and a 44.5 ± 9.7% decrease in maximal respiration. PARIS overexpression reduced mitochondrial reserve capacity by 69.0 ± 7.8 (n = 5 assays). Concurrent overexpression of PGC-1α rescued these phenotypes (n = 4 assays). Data are expressed as mean ± SEM. The results were evaluated for statistical significance using one-way ANOVA with Tukey's post hoc test (C-E). Differences were considered significant when *P < 0.05, ***P < 0.001.
